Neuroendocrine tumours of the pancreas: Recent developments in staging and grading

Diagnostic Histopathology

Volumn 18, Issue 1, 2012, Pages 1-7

  Couvelard, Anne ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Classification; Grading; Neuroendocrine tumours; Pancreas; Staging; TNM; WHO

Indexed keywords

CHROMOGRANIN A; KI 67 ANTIGEN; SYNAPTOPHYSIN;

ADENOCARCINOMA; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CARCINOID; CARCINOMA; CELL PROLIFERATION; DISTANT METASTASIS; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; MITOSIS RATE; NEUROENDOCRINE TUMOR; PANCREAS TUMOR; PHENOTYPE; PROGNOSIS; TUMOR BIOPSY; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

EID: 84655167234     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2011.10.008     Document Type: Article

References (21)

1. Histological typing of endocrine tumours. WHO international histological classification of tumours 2000, Springer, Berlin. 2nd edn. E. Solcia, G. Klöppel, L.H. Sobin (Eds.).
2. Pathology and genetics of tumours of endocrine organs 2004, IARC Press, Lyon. R.A. DeLellis, R.V. Lloyd, P.U. Heitz, C. Eng (Eds.).
3. Rindi G., Klöppel G., Alhman H., et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006, 449:395-401.
4. Rindi G., Klöppel G., Couvelard A., et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007, 451:757-762.
5. Scarpa A., Mantovani W., Capelli P., et al. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol 2010, 23:824-833.
6. Hochwald S.N., Zee S., Conlon K.C., et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups. JClin Oncol 2002, 20:2633-2642.
7. Pape U.F., Berndt U., Müller-Nordhorn J., et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer 2008, 15:1083-1097.
8. Klöppel G., Couvelard A., Perren A., et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009, 90:162-166.
9. Pape U.F., Jann H., Müller-Nordhorn J., et al. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 2008, 113:256-265.
10. Ekeblad S., Skogseid B., Dunder K., Oberg K., Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin Cancer Res 2008, 14:7798-7803.
11. Fischer L., Kleeff J., Esposito I., et al. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br J Surg 2008, 95:627-635.
12. La Rosa S., Klersy C., Uccella S., et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009, 40:30-40.
13. Jann H., Roll S., Couvelard A., et al. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome. Cancer 2011, 117:3332-3341.
14. TNM classification of malignant tumors 2009, Springer, Heidelberg. 7th edn. L.H. Sobin, M.A. Gospodarowicz, C. Wittekind (Eds.).
15. Klimstra D.S., Modlin I.R., Adsay N.V., et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010, 34:300-313.
16. Klöppel G., Rindi G., Perren A., Komminoth P., Klimstra D.S. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 2010, 456:595-597.
17. Strosberg J.R., Cheema A., Weber J., Han G., Coppola D., Kvols L.K. Prognostic validity of a novel American Joint Committee on Cancer staging classification for pancreatic neuroendocrine tumours. J Clin Oncol 2011, 29:3044-3049.
18. WHO classificationof tumors of the digestive system 2010, IARC, Lyon. 4th edn. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).
19. WHO classification of tumours. Pathology and genetics. Tumours of the lung, pleura, thymus and heart 2004, IARC, Lyon. W.D. Travis, E. Brambilla, H.K. Müller-Hermelink, C.C. Harris (Eds.).
20. Miettinen M., Lasota J. Gastrointestinal stromal tumors: pathology andprognosis at different sites. Semin Diagn Pathol 2006, 23:70-83.
21. Rindi G., Klimstra D.S., Arnold R., et al. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. WHO classification of tumors of the digestive system 2010, 13-14. IARC, Lyon. 4th edn. F.T. Bosman, F. Carneiro, R.H. Hruban, N.D. Theise (Eds.).